New research is being presented at the AHA Scientific Sessions 2012—the American Heart Association’s annual meeting—from November 3-7 in Los Angeles. The features below highlight just some of the studies that emerged from the conference.
Meeting Highlights
Experimental Combination Drug Yields Cardiovascular Benefits
Can Daily Multivitamins Prevent CVD?
Comparing Revascularization Approaches in Patients With Diabetes & CAD
Examining Follow-Up Costs for Angioplasty
News from the Scientific Sessions
People in ‘crowdsourcing’ challenge find defibrillators in Philadelphia
Japanese family members less likely than others to give CPR for cardiac arrest
Recreational cocaine use linked to conditions that cause heart attack
People more likely to take heart medicines in combo pill
“Good” cholesterol drug doesn’t reduce risks in heart patients
Stem cells from patients or donors may help treat diseased hearts
Telltale visible signs of aging may predict heart disease
Heart-related deaths increase in winter regardless of climate
High blood pressure in young adults likely to go undiagnosed
Drug trio improved effectiveness of cancer treatment, protected heart
Short-term fish oil use doesn’t quell irregular heart rhythm after heart surgery
Genetically engineered tomatoes decrease plaque build-up in mice
Infusing ‘good’ cholesterol protein may lower risk of subsequent heart attack
Daily doses of a new probiotic reduces ‘bad’ and total cholesterol
Heart attack packs a wallop to wallet of survivors, their employers
Chelation therapy doesn’t alter quality of life in heart attack patients
Alternative therapy produces intriguing results in some heart patients but many questions remain
New device could allow your heartbeat to power pacemaker
More from the Scientific Sessions
ReSuscitation Science Symposium
Case Theaters: Learning at the Movies
Cardiovascular Nursing Clinical Symposium
AHA Cardiovascular Evening Symposium
Clinical Science: Special Reports
Late-Breaking Clinical Trials News
Top Scoring Abstracts and Poster Winners
